Market Analysis
Why Did Archer Aviation Stock Drop in Premarket Today?
Archer Aviation stock fell about 10% in premarket trading after posting a larger quarterly loss and unveiling a $126 million airport acquisition.
Total Stories
2,511
News
stocks
Section
stocks
Earnings
KKR & Co. Inc. Reports Mixed Q3 2025 Results with EPS Beat and Revenue Shortfall
KKR posted Q3 EPS of $1.41 and revenue of $1.74 billion, delivering mixed results but maintaining an optimistic outlook focused on strategic growth.
Uncategorized
Why Apple’s AI Caution May Become its Advantage
As tech giants race to outspend each other on AI, Apple’s restraint could prove to be its most valuable innovation yet.
Market Analysis
D-Wave Quantum Stock Falls Despite Q3 Results Surpassing Estimates
Despite beating Q3 estimates, D-Wave shares fell 4% as investors took profits following a 2,000% gain over the past year.
Market Analysis
Snap Stock Jumps on $400 Million AI Partnership With Perplexity
Snap stock surged 18% on news of a $400 million AI partnership with Perplexity, set to bring conversational search to Snapchat in 2026.
Earnings
TC Energy Q3 Results Beat EPS Estimates, Updates Long-Term Outlook
TC Energy beat EPS estimates with $0.77 per share on $2.65 billion in revenue and issued guidance through 2028.
Earnings
EchoStar Reports Major Q3 Setback, Driven by $12.8 Billion Write-Down
EchoStar reported a difficult third quarter with heavy losses but remains optimistic about recovery, backed by new investments and major spectrum deals.
Earnings
Air Products (APD) Reports 2025 Fourth Quarter Results
Air Products reported Q4 adjusted EPS of $3.39 on revenue of $3.2 billion, with 2026 guidance projecting steady earnings growth and continued operational strength.
Market Analysis
Axon Stock Slumps 20% After Q3 Profit Miss Amid Tariff-Driven Cost Surge
Axon shares dropped 20% after reporting a Q3 profit miss tied to tariff costs, though revenue exceeded forecasts at $710.6 million.
Market Analysis
Why Did Biohaven Stock Collapse in Premarket Today? FDA Rejects Its Lead Drug Vyglxia
Biohaven dropped 44% in premarket trading after the FDA declined to approve Vyglxia, citing issues with trial design even as data showed slower disease progression.
Earnings
McDonald’s (MCD) Reports Q3 2025 Results: EPS Misses but Sales Stay Solid
McDonald's Q3 2025 results showed a 3.6% rise in global sales, while EPS of $3.18 came in just below forecasts.
Earnings
Emerson (EMR) Reports Q4 Results with Revenue Slightly Below Estimates
Emerson’s Q4 2025 results showed steady growth, with EPS meeting expectations and revenue slightly below estimates.
Earnings
Humana Reports Q3 Earnings Beat, Maintains Full-Year EPS Forecast
Humana’s third-quarter results beat expectations with adjusted EPS of $3.24 and revenue of $32.65 billion, as the company reaffirmed its full-year EPS guidance.